Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating expenses
General and administrative	$ 8,852,021	$ 11,605,761
Research and development	7,252,437	8,027,773
Impairment of intangible assets and goodwill		7,453,662
Depreciation and amortization	343,982	327,910
Total operating expenses	16,448,440	27,415,106
Loss from operations	(16,448,440)	(27,415,106)
Other (expense) income
Inducement expense, net	(1,848,235)
Change in fair value of warrant liabilities	94,396	4,315,236
Change in fair value of investment option liability	208,752	3,472,726
Change in fair value of derivative liability	727,000	(325,000)
Interest income (expense), net	3,708	(5,249)
Total other (expense) income	(814,379)	7,457,713
Net loss before income taxes	(17,262,819)	(19,957,393)
Income tax (expense) benefit	(28,913)	1,486,060
Net loss	(17,291,732)	(18,471,333)
Less preferred dividends attributable to non-controlling interest	19,041	33,014
Less deemed dividends attributable to accretion of embedded derivative at redemption value	147,988	295,976
Net loss attributable to shareholders	(17,458,761)	(18,800,323)
Other comprehensive loss
Foreign currency translation	(33,015)	(505,932)
Comprehensive loss	$ (17,491,776)	$ (19,306,255)
Net loss per share - basic	$ (8.09)	$ (13.00)
Net loss per share - diluted	$ (8.09)	$ (13.00)
Weighted average shares outstanding, basic	2,159,063	1,446,007
Weighted average shares outstanding, diluted	2,159,063	1,446,007